BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25822169)

  • 1. The experience of pain and redness in patients with moderate to severe plaque psoriasis.
    Martin ML; Gordon K; Pinto L; Bushnell DM; Chau D; Viswanathan HN
    J Dermatolog Treat; 2015 Oct; 26(5):401-5. PubMed ID: 25822169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity.
    Martin ML; McCarrier KP; Chiou CF; Gordon K; Kimball AB; Van Voorhees AS; Gottlieb AB; Huang X; Globe D; Chau D; Viswanathan HN; Kricorian G
    J Dermatolog Treat; 2013 Aug; 24(4):255-60. PubMed ID: 23249143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument.
    Lebwohl M; Swensen AR; Nyirady J; Kim E; Gwaltney CJ; Strober BE
    Int J Dermatol; 2014 Jun; 53(6):714-22. PubMed ID: 23557000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP).
    Burden AD; Mrowietz U; Skalicky AM; Rentz AM; Esser D; Gloede T; Thoma C; Menter A
    Dermatol Ther (Heidelb); 2022 Jun; 12(6):1367-1381. PubMed ID: 35590037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The content validity of the PSS in patients with plaque psoriasis.
    Rentz AM; Skalicky AM; Burslem K; Becker K; Kaschinski D; Esser D; Revicki DA
    J Patient Rep Outcomes; 2017; 1(1):4. PubMed ID: 29757301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis.
    Viswanathan HN; Chau D; Milmont CE; Yang W; Erondu N; Revicki DA; Klekotka P
    J Dermatolog Treat; 2015 Jun; 26(3):235-9. PubMed ID: 25078334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity.
    Bushnell DM; Martin ML; McCarrier K; Gordon K; Chiou CF; Huang X; Ortmeier B; Kricorian G
    J Dermatolog Treat; 2013 Oct; 24(5):356-60. PubMed ID: 23092173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions.
    Tatlock S; Rüdell K; Panter C; Arbuckle R; Harrold LR; Taylor WJ; Symonds T
    Patient; 2017 Feb; 10(1):65-79. PubMed ID: 27384670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical symptoms and self-reported disease severity among patients with psoriasis - Implications for psoriasis management.
    Korman NJ; Zhao Y; Li Y; Liao M; Tran MH
    J Dermatolog Treat; 2015; 26(6):514-9. PubMed ID: 25886083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex experience of psoriasis related skin pain: a qualitative study.
    Ljosaa TM; Bondevik H; Halvorsen JA; Carr E; Wahl AK
    Scand J Pain; 2020 Jul; 20(3):491-498. PubMed ID: 32101532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.
    Feldman SR; Bushnell DM; Klekotka PA; Scanlon M; Martin ML; Wade SW; Yang W; Pinto L; Kircik L; Viswanathan HN
    J Dermatolog Treat; 2016; 27(3):224-7. PubMed ID: 26447179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis.
    Viswanathan HN; Mutebi A; Milmont CE; Gordon K; Wilson H; Zhang H; Klekotka PA; Revicki DA; Augustin M; Kricorian G; Nirula A; Strober B
    Value Health; 2017 Sep; 20(8):1174-1179. PubMed ID: 28964451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and markers of symptom severity in asthma--content validity of the asthma symptom diary.
    Globe G; Martin M; Schatz M; Wiklund I; Lin J; von Maltzahn R; Mattera MS
    Health Qual Life Outcomes; 2015 Feb; 13():21. PubMed ID: 25879643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis.
    Sobell JM; Foley P; Toth D; Mrowietz U; Girolomoni G; Goncalves J; Day RM; Chen R; Yosipovitch G
    Acta Derm Venereol; 2016 May; 96(4):514-20. PubMed ID: 26837052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis.
    Pariser D; Schenkel B; Carter C; Farahi K; Brown TM; Ellis CN;
    J Dermatolog Treat; 2016; 27(1):19-26. PubMed ID: 26138406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis.
    Naegeli AN; Flood E; Tucker J; Devlen J; Edson-Heredia E
    Int J Dermatol; 2015 Jun; 54(6):715-22. PubMed ID: 25515935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials.
    Kimball AB; Luger T; Gottlieb A; Puig L; Kaufmann R; Nikaï E; Zhu B; Edson-Heredia E; Carlier H; Lin CY; Goldblum O; Yosipovitch G
    J Am Acad Dermatol; 2016 Dec; 75(6):1156-1161. PubMed ID: 27692498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis.
    Safikhani S; Sundaram M; Bao Y; Mulani P; Revicki DA
    J Dermatolog Treat; 2013 Feb; 24(1):50-9. PubMed ID: 22007701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
    Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) - clinical trial and the SAPS - real world patient-reported outcomes.
    Armstrong AW; Banderas B; Foley C; Stokes J; Sundaram M; Shields AL
    J Dermatolog Treat; 2017 Sep; 28(6):505-514. PubMed ID: 28147886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.